Carnegie acted as adviser to Medivir, and underwriter, in the company’s SEK 325 million rights offering. Medivir develops pharmaceuticals against major, widespread diseases, focusing on pharmaceuticals against infectious diseases caused by viruses. June, 2010
Healthcare
Rights offering in Medivir (SE) — SEK 325 million
June 2010